- All Journals
- Al-Qadisiyah University
- Basrah University
- Kirkuk University
- Mosul University
- The Iraqi Borad for Medical Specialization
- University of Anbar
- University of Technology
- Al Mustafa University
- Al-Zahraa University for Women
- Alnoor University
- Kunooz University
- Misan University
- Ninevah University
- Tikrit University
- University of Al-Hamdaniya
- University of Kerbala
Azithromycin macrolids with a potent activity on chronic experimental toxopiasmosis | ||
| Iraqi Journal of Pharmacy | ||
| Article 1, Volume 6, Issue 1, 2006, Pages 1-5 PDF (0 K) | ||
| DOI: 10.33899/iphr.2006.50532 | ||
| Author | ||
| Sabah Saeid Mahmoud | ||
| Abstract | ||
| Objective: To assess the efficacy of Azithromycin, a macrolids antibiotic, againsst experimentally induced toxopiasmosis in marine model Design: Experimental study. Setting: Department of Microbiology, Nineveh College of Medicine, from October 2004 to November 2005. Results: The efficacy of Azithromycin against Toxoplasma gondii was examined in murine models of infection with a moderately virulent strain. Forty white Albino mice inoculated by mouth with 2x 10 cysts, 20 mice were treated with Azithromycin at dose of 250 mg/kg /day for 90 days. Drug treatment was initiated 30 days after infection (chronic infection). Treatment with Azithromycin significantly enhanced survival and reduced the brain cyst burden as compared with untreated (control) group of mice. Since 80% of treated mice were cornp>letely cured from toxopiasmosis as their brain were free of Toxoplasma tissue cysts either microscopically or by bioassay. Conclusion: The results warrant clinical evaluation of Azithromycin in the treatment of toxopiasmosis in both immunocompetent and immunocompromised patients. | ||
|
Statistics Article View: 550 PDF Download: 393 |
||